Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin for Early-Onset Intrauterine Growth Restriction in Pregnancy
IRCT20251208068251N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Feb 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of enoxaparin in intrauterine growth restriction (IUGR), sponsored by Qazvin University of Medical Sciences. Started Feb 2026; status: completed.
02
Drugs
enoxaparin
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on IRCT20251208068251N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251208068251N1.